StemCells' IPO

StemCells raised a round of funding on July 19, 2004. Investors include Public.

StemCells (NASDAQ: STEM) is engaged in clinical development of its proprietary HuCNS-SC (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CN…

Articles about StemCells' IPO: